Characterization of CB1 cannabinoid receptors using receptor peptide fragments and site-directed antibodies

Molecular Pharmacology

Volumn 53, Issue 3, 1998, Pages 504-510

  Howlett, Allyn C ^a,c   Song, Chao ^a,b   Berglund, Barbara A ^a   Wilken, Gerald H ^a   Pigg, J Jill ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c Dept Pharmacol Physiological Sci ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ADENYLATE CYCLASE; CANNABINOID RECEPTOR; GUANOSINE DERIVATIVE; IMMUNOGLOBULIN G; PEPTIDE FRAGMENT; ANTISERUM; DRUG RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVITY; ENZYME INHIBITION; MEMBRANE BINDING; PRIORITY JOURNAL; RECEPTOR BINDING; ANIMAL; BINDING SITE; CHEMISTRY; DRUG ANTAGONISM; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; RABBIT; RAT;

ADENYLATE CYCLASE; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; GTP-BINDING PROTEINS; IMMUNE SERA; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RABBITS; RATS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0031594615     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.53.3.504     Document Type: Article

References (38)

1. 2 dopamine receptor antibodies using sequence-specific peptides. Mol Pharmacol 43:666-676.
2. s by synthetic peptides corresponding to an intracellular loop of the betaadrenergic receptor. FEBS Lett 279:277-280.
3. 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc Natl Acad Sci USA 87:2896-2900.
4. 2A-adrenergic receptor alter receptor G protein coupling by distinct mechanisms. J Biol Chem 266:11025-11029.
5. Devane WA, Dysarz FA 3d, Johnson MR, Melvin LS, and Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613.
6. Dixon RA, Sigal IS, Candelore MR, Register RB, Scattergood W, Rands E, and Strader CD (1987) Structural features required for ligand binding to the β-adrenergic receptor. EMBO J 6:3269-3275.
7. Garibay JLR, Kozasa T, Itoh H, Tsukamoto T, Matsuoka M, and Kaziro Y (1991) Analysis by mRNA levels of the expression of six G protein α-subunit genes in mammalian cells and tissues. Biochim Biophys Acta 1094:193-199.
8. Gerard CM, Mollereau C, Vassart G, and Parmentier M (1991) Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J 279: 129-134.
9. s. J Biol Chem 265:1388-1393.
10. Hawes BE, Luttrell LM, Exum ST, and Lefkowitz RJ (1994) Inhibition of G protein-coupled receptor signaling by expression of cytoplasmic domains of the receptor. J Biol Chem 269:15776-16785.
11. Hogger P, Shockley MS, Lameh J, and Sadee W (1995) Activating and inactivating mutations in N- and C-terminal i3 loop junctions of muscarinic acetylcholine Hm1 receptors. J Biol Chem 270:7405-7410.
12. Houston DB and Howlett AC (1993) Solubilization of the cannabinoid receptor from rat brain and its functional interaction with guanine nucleotide-binding proteins. Mol Pharmacol 43:17-22.
13. Howlett AC (1985) Cannabinoid inhibition of adenylate cyclase: biochemistry of the response in neuroblastoma cell membranes. Mol Pharmacol 27:429-436.
14. Howlett AC (1995a) Cannabinoid compounds and signal transduction mechanisms, in Cannabinoid Receptors: Molecular Biology and Pharmacology (Pertwee RG, ed) pp 167-204, Academic Press, London.
15. Howlett AC (1995b) Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35:607-634.
16. Konig B, Arendt A, McDowell J, Kahlert M, Hargrave P, and Hofmann K (1989) Three cytoplasmic loops of rhodopsin interact with transducin. Proc Natl Acad Sci USA 86:6878-6882.
17. Liu J, Conklin B, Blin N, Yun J, and Wess J (1995) Identification of a receptor/G-protein contact site critical for signaling specificity and G-protein activation. Proc Natl Acad Sci USA 92:11642-11646.
18. 35S)thio)triphosphate binding. Mol Pharmacol 44:115-133.
19. Luttrell LM, Ostrowski J, Cotecchia S, Kendall H, and Lefkowitz RJ (1993) Antagonism of catecholamine receptor signaling by expression of cytoplasmic domains of the receptors. Science (Washington DC) 259:1453-1457.
20. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, and Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (Lond) 346:561-564.
21. Munch G, Dees C, Hekman M, and Palm D (1991) Multisite contacts involved in coupling of the β-adrenergic receptor with the stimulatory guanine-nucleotide-binding regulatory protein: structural and functional studies by β-receptor-site-specific synthetic peptides. Eur J Biochem 198:357-364.
22. 2-adrenergic receptor: localization of regions involved in G protein-receptor coupling. J Biol Chem 263:15985-15992.
23. 2a-adrenergic receptor-GTP-binding protein complexes using GTP-binding protein selective antisera: changes in receptor/GTP-binding protein interaction following agonist binding. J Biol Chem 267:14826-14831.
24. Osawa S and Weiss E (1994) The carboxyl terminus of bovine rhodopsin is not required for G protein activation. Mol Pharmacol 46:1036-1040.
25. Phillips WJ and Cerione RA (1994) A C-terminal peptide of bovine rhodopsin binds to transducin α-subunit and facilitates its activation. Biochem J 299:351-357.
26. Pinto JC, Potie F, Rice KC, Boring D, Johnson MR, Evans DM, Wilken GH, Cantrell CH, and Hewlett AC (1994) Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid. Mol Pharmacol 46:516-522.
27. Poddar MK, Ghosh SK, and Haque SJ (1988) Cannabinoids and fatty acids: interaction with bovine serum albumin, in Marijuana: An International Research Report (Chesher G, Consroe P, and Musty R, eds) pp 309-314, Australian Government Public Service, Canberra.
28. 2-adrenergic receptor. J Biol Chem 268:16483-16487.
29. Schreiber R, Prossnitz E, Ye R, Cochrane C, and Bokoch G (1994) Domains of the human neutrophil N-formyl peptide receptor involved in G protein coupling: mapping with receptor-derived peptides. J Biol Chem 269 326-331.
30. t. J Biol Chem 270: 2112-2119.
31. Song C and Howlett AC (1995) Rat brain cannabinoid receptors are N-linked glycosylated proteins. Life Sci 56:1983-1989.
32. Takemoto D, Takemoto L, Hansen J, and Morrison D (1985) Regulation of retinal transducin by C-terminal peptides of rhodopsin. Biochem J 232:669-672.
33. Wade SM, Dalman HM, Yang S-Z, and Neubig RR (1994) Multisite interactions of receptors and G proteins: enhanced potency of dimeric receptor peptides in modifying G protein function. Mol Pharmacol 45 1191-1197.
34. Wahlqvist M, Nilsson IM, Sandberg F, and Agurell S (1970) Binding of delta-1-tetrahydrocannabinol to human plasma proteins. Biochem Pharmacol 19:2579-2584.
35. Weiss ER, Kelleher DJ, and Johnson GL (1988) Mapping sites of interaction between rhodopsin and transducin using rhodopsin antipeptide antibodies. J Biol Chem 263:6150-6154.
36. Widman M, Agurell S, Ehrnebo M, and Jones G (1974) Binding of (+)- and (-)-delta-1-tetrahydrocannabinols and (-)-7-hydroxy-delta-1-tetrahydrocannabinol to blood cells and plasma proteins in man. J Pharm Pharmacol 26:914-916.
37. s in response to muscarinic agonists. J Biol Chem 265:6219-6224.
38. Yamada M, Yamada M, Watson MA, and Richelson E (1994) Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells. Mol Pharmacol 46:470-475.